Abstract
We have previously reported sex- and estrous-related differences in hostresistance to the metastatic development of a mammary adenocarcinoma cellline, MADB106, in the Fischer 344 (F344) rat. In other studies, we foundthat surgery suppressed natural killer (NK) cell activity and increased theNK-sensitive metastatic development of MADB106 tumor cells. The currentstudy was designed to explore whether sex or estrous phase at the time ofsurgery impacts the degree of such deleterious effects of surgery. Suchestrous effects could be related to an ongoing clinical debate regarding theimportance of the timing of breast cancer surgery with the menstrual cyclein premenopausal women. Mature F344 males and cycling females underwenteither experimental laparotomy with halothane anesthesia, halothaneanesthesia alone, or were untreated. Five hours after surgery, animalseither were injected with radiolabeled MADB106 tumor cells and assessed forlung tumor cell retention 12 hours later, or underwent blood withdrawal forin vitro assessment of NK cell activity. MADB106 tumor cells metastasizeonly to the lungs, and lung tumor cell retention is: a) an early indicatorof the number of metastases that would develop weeks later, and b) highlysensitive to in vivo levels of NK activity. This mammary adenocarcinoma cellline is syngeneic to the inbred F344 strain of rats used in our studies,thus constituting a model for breast cancer metastasis. The resultsindicated that sex, estrous phase, and surgery interacted in their effectson NK cell activity and tumor metastasis. MADB106 lung tumor cell retentionwas increased by surgery in both sexes (2- to 3-fold) compared to theanesthesia only and control groups. This increase, however, wassignificantly greater in proestrus/estrus (P/E) females than inmetestrus/diestrus (M/D) females. Among the control animals, females in P/Eexhibited significantly less NK cytotoxic activity compared to the males,and the NK activity exhibited by females in M/D was between these twogroups. Surgery suppressed NK cytotoxic activity to a similar level in allgroups. Possible implications of these findings for the surgical care ofwomen with breast cancer are discussed.
Similar content being viewed by others
References
Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Dubens RD, Fentiman IS: Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 33: 1261–1264, 1991
Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD: Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 30A: 445–448, 1994
Hrushesky WJM, Bluming AZ, Gruber SA, Sothern RB: Menstrual influence on surgical cure of breast cancer. Lancet ii: 949–952, 1989
Kurebayashi J, Sonoo H, Shimozuma K: Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer. Jpn J Surg 25: 519–524, 1995
Saad Z, Bramwell V, Duff J, Girotti M, Jory T, Heathcote G, Turnbull I, Garcia B, Stitt L: Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br J Surg 81: 217–220, 1994
Sainsbury R, Jones M, Parker D, Hall R, Close H: Timing of surgery for breast cancer and menstrual cycle (letter). Lancet 338: 392, 1991
Senie RT, Rosen PP, Rhodes P, Lesser ML: Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Int Med 115: 337–342, 1991
Spratt JS, Zirnheld J, Yancey JM: Breast Cancer Detection Demonstration Project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle. J Surg Oncol 53: 4–9, 1993
Veronesi U, Luini A, Mariani L, Del Vecchio M, Alvez D, Andreoli C, Giacobone A, Merson M, Pacetti G, Raselli R, Saccozzi R: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343: 1544–1546, 1994
Donegan WL, Shah D: Prognosis of patients with breast cancer related to the timing of operation. Arch Surg 128: 309–313, 1993
Gnant MFX, Seifert M, Jakesz R, Adler A, Mittlboeck M, Sevelda P: Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women. Int J Cancer 52: 707–712, 1992
Jäger W, Sauerbrei W: Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients. Br Cancer Res Treat 34: 279–287, 1995
Kroman N, Højgaard A, Anderson K, Graversen HP, Afzelius P, Lokdam A, Juul C, Hoffman J, Bentzon N, Mouridsen HT: Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Eur J Surg Oncol 20: 430–435, 1994
Nathan B, Bates T, Anbazhagan R, Norman AR: Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal women. Br J Surg 80: 43, 1993
Powles TJ, Jones AL, Ashley S, Tidy A: Menstrual effect on surgical cure of breast cancer (letter). Lancet 2: 1343–1344, 1989
Ben-Eliyahu S, Page GG, Shakhar G, Taylor AN: Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: Possible role of oestradiol and natural killer cells. Br J Cancer 74: 1900–1907, 1996
Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW: Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134: 2783–2789, 1985
Ben-Eliyahu S, Page GG: The in vivo assessment of natural killer cell activity in rats. Prog Neuroendocrinimmunol 5: 199–214, 1992
Van den Brink MRM, Hunt LE, Hiserodt JC: In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 171: 197–210, 1990
Gruber SA, Hoffman RA, Sothern RB, Lakatua D, Carlson A, Simmons RL, Hrushesky WJM: Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery 104: 398–403, 1988
Hrushesky WJM, Gruber SAS, Sothern RB, Hoffman RA, Lakatua D, Carlson A, Cerra F, Simmons RL: Natural killer cell activity: Age, estrous-and circadian-stage dependence and inverse correlation with metastatic potential. J Nat Cancer Inst 80: 1232–1237, 1988
Sulke AN, Jones DB, Wood PJ: Variation in natural killer activity in peripheral blood during the menstrual cycle. Br Med J 290: 884–886, 1985
White D, Jones DB, Cooke T, Kirkham N: Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. Br J Cancer 46: 611–616, 1982
Page GG, Ben-Eliyahu S, Liebeskind JC: The role of LGL/MK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun 8: 241–250, 1994
Pollock RE, Babcock GF, Romsdahl MM, Nishioka K: Surgical stress-mediated suppression of murine natural killer cell cytotoxicity. Cancer Res 44: 3888–3891, 1984
Toge T, Hirai T, Takiyama W, Hattori T: Effects of surgical stress on natural killer activity, proliferative response of spleen cells and cytostatic activity of lung macrophages in rats. Gann 72: 790–794, 1981
McCulloch PG, MacIntyre A: Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg 80: 1005–1007, 1993
Pollock RE, Lotzová E, Stanford SD: Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch Surg 126: 338–342, 1991
Pollock RE, Lotzová E, Stanford SD: Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer 70: 2192–2202, 1992
Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC: Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54: 21–28, 1993
Hattori T, Hamai Y, Harada T, Ikeda H, Ikeda T: Enhancing effect of thoracotomy and/or laparotomy on the development of the lung metastases in rats after intravenous inoculation of tumor cells. Jap J Surg 7: 263–268, 1977
Fidler IJ: Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-Iodo-2′-deoxyuridine. J Nat Cancer Inst 45: 773–782, 1970
Everett JW: Neurobiology of Reproduction in the Female Rat. Springer-Verlag, Berlin, 1989, pp 133
Tønnesen E, Brinkløv MM, Christensen NJ, Olesen AS, Madsen T: Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response. Anesthesiology 67: 526–533, 1987
Lundy J, Lovett EJ, Hamilton S, Conran P: Halothane, surgery, immunosuppression and artificial pulmonary metastases. Cancer 41: 827–830, 1978
Takekoshi T, Sakata K, Kunieda T, Saji S, Tanemura H, Yamamoto S: Facilitation of tumor metastasis by operative stress and participation of cell-mediated immunity. Oncology 41: 245–251, 1984
Tanemura H, Sakata K, Kunieda T, Saji S, Yamamoto S, Takekoshi T: Influences of operative stress on cell-mediated immunity and on tumor metastasis and their prevention by nonspecific immunotherapy: Experimental studies in rats. J Surg Oncol 21: 189–195, 1982
Thyss A, Caldani C, Bourcier C, Benita G, Schneider M: Comparison of natural killer activity during the first and second halves of the menstrual cycle in women (letter). Br J Cancer 50: 127–128, 1984
Pross HF, Lotzová E: Role of natural killer cells in cancer. Nat Immun 12: 279–292, 1993
Trinchieri G: Biology of natural killer cells. Adv Immunol 47: 187–376, 1989
Levy SM, Herberman RB, Maluish AM, Schlien B, Lippman M: Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 4: 99–113, 1985
Schantz SP, Brown BW, Lira E, Taylor DL, Beddingfield N: Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25: 141–145, 1987
Tartter PI, Steinberg B, Barron DM, Martinelli G: The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 122: 1264–1268, 1987
Benner BG, Margolese RG: The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer 68: 482–488, 1991
Zielinski CC, Tichatschek E, Muller C, Kalinowski W, Sevelda P, Czerwenka D, Kubista E, Spona J: Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer. Cancer 63: 1985–1989, 1989
Uchida A, Kolb R, Micksche M: Generation of suppressor cells for natural killer activity in cancer patients after surgery. J Nat Cancer Inst 68: 735–741, 1982
Sachs G, Rasoul-Rockenschaub S, Aschauer H, Spiess K, Gober I, Staffen A, Zielinski C: Lytic effector cell activity and major depressive disorder in patients with breast cancer: A prospective study. J Neuroimmunol 1–2: 83–89, 1995
Konjevic G, Spuzic I: Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma 40: 81–85, 1993
Garzetto GG, Civattini A, Goteri G, Tranquilli AL, Muzzioli M, Fabris N, De Nictolis M, Romanini C: Natural killer cell activity in Stage I endometrial carcinoma: Correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen. Gynecol Oncol 55: 111–114, 1994
Park SK, Brody JI, Wallace HA, Blakemore WS: Immunosuppressive effect of surgery. Lancet 7688: 53–55, 1971
Tønnesen E: Immunological aspects of anaesthesia and surgery — with special reference to NK cells. Dan Med Bull 36: 263–281, 1989
Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 30: 107–112, 1982
Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Nat Cancer Inst 65: 801–809, 1980
Wiltrout RH, Herberman RB, Zhang S, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE: Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134: 4267–4275, 1985
Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP: Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behav Immun 5: 193–205, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Page, G.G., Ben-Eliyahu, S. Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats. Breast Cancer Res Treat 45, 159–167 (1997). https://doi.org/10.1023/A:1005826403235
Issue Date:
DOI: https://doi.org/10.1023/A:1005826403235